INS and breast cancer: Furthermore, patients with metabolic syndrome present with a lower amount of EVs with medium size, which was related to fasting insulin levels accompanied by consequences of insulin sensitivity, while studies show leptin to mediate the release of EVs from breast cancer cells [44,45].